Issue 16, 2012

Di-nuclear nonionic magnetic resonance contrast agents using pyrazinyl linking centers

Abstract

Two di-nuclear non-ionic MRI contrast agents, (Gd-DO3A)2-BMQX and (Gd-DO3A)2-BMP, have been designed and synthesized by fusing the DO3A units together with a quinoxalinyl or pyrazinyl moiety. They have improved longitudinal relaxivities of 5.23 and 5.16 mM Gd−1 s−1, respectively, at 20 MHz magnet, 37 °C and pH 7.0. In addition, they possess high thermodynamic stability and kinetic inertness. The cytotoxicity studies indicated that the toxicity of these two agents were low. All these properties satisfy the requirements for clinical applications.

Graphical abstract: Di-nuclear nonionic magnetic resonance contrast agents using pyrazinyl linking centers

Supplementary files

Article information

Article type
Communication
Submitted
12 Mar 2012
Accepted
13 Apr 2012
First published
18 Apr 2012

RSC Adv., 2012,2, 6404-6407

Di-nuclear nonionic magnetic resonance contrast agents using pyrazinyl linking centers

G. zhao, H. Li, C. Lu, Y. Xiao, X. Fang, P. Wang, X. Fang, K. Zhao, X. Li, S. Yin, J. Xu and W. Yang, RSC Adv., 2012, 2, 6404 DOI: 10.1039/C2RA20450A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements